Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280756 · ClinicalTrials.gov registry record · NA
Home-based tDCS for Prevention of Suicidal Ideation
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05280756 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 33 participants.
The verdict
NCT05280756, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Risk for suicide is elevated in the period after discharge from hospital among adults with major affective disorder. The primary objective of this study is to investigate the feasibility of delivering tDCS sessions for high-risk patients for suicide at home in the days following discharge from an emergency department or inpatient unit. This is a single-center, randomized, sham-controlled, double-blind clinical study. We plan to assess up to 80 adult patients for eligibility over 12 months of which 20 will be enrolled and randomized. Clinical assessments will be performed at baseline, post-treatment day 14 (14 days after the first tDCS session), and follow-up day 30 and 60 (30 and 60 days after the first tDCS session, respectively).
Interventions
- DEVICE Home-based transcranial direct current stimulation (tDCS)
- DEVICE Sham home-based transcranial direct current stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2024-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05280756
The ClinicalTrials.gov registry entry for NCT05280756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Home-based transcranial direct current stimulation (tDCS) is the first listed.
NCT05280756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05280756 about?
NCT05280756 is a clinical study titled "Home-based tDCS for Prevention of Suicidal Ideation". Risk for suicide is elevated in the period after discharge from hospital among adults with major affective disorder. The primary objective of this study is to investigate the feasibility of delivering tDCS sessions for high-risk patients for suicide at home in the days following discharge from an em...
What is the current status of trial NCT05280756?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2023-09-21. Estimated completion is 2024-06-11.
What interventions are being tested in trial NCT05280756?
The interventions under investigation include: Home-based transcranial direct current stimulation (tDCS) (DEVICE), Sham home-based transcranial direct current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT05280756?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.